Analyzing CD7 positivity in AML samples with minimally differentiated blast cells, a lower CD44 expression [median 23.0 (7.2–98.3)] was found, compared to CD7 negative AML [median 409.7 (311.1–545.7)] (p = 0.004; Figure 2C). Here, CD44 is linked to acute myeloid leukemia.